AHPA letter corrects New York Times' inaccurate coverage of GNC deal

New York Times published McGuffin's letter to the editor in response to an inaccurate editorial and article about the New York attorney general's agreement with GNC.

The New York Times on April 9 published a letter to the editor by American Herbal Products Association (AHPA) President Michael McGuffin in response to an inaccurate editorial and article about the New York attorney general's (AG's) agreement with GNC. 

In the letter, McGuffin stresses that the AG's agreement with GNC stated that the AG found no evidence that GNC deviated from the federal current good manufacturing practice (cGMP) rules. And that the cGMP rules require, among many other controls, that dietary supplements meet all specifications, including for identity and contaminants. 

"In other words and contrary to the original allegation, the attorney general determined that there was no contamination or substitution in the tested GNC products," McGuffin's letter to the editor states.

Read McGuffin's letter to the editor.

 

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish